Sure it is early -- but we have so much more than we expected --- perhaps even at much later points in the current 2a trial. Based on the conference call, I would think they should see as good if not better results with the new cohort (partial spinal fractures, not total). And they can work long term toward giving everyone 20m cells - the newly approved number that they have yet to use. That seems to be the most impressive thing here - better, earlier results and not even using the max dosage yet. Hard not to get excited.
It is early in this trial. But this is a platform drug opportunity where it looks like their first go (trial paid for partially by partner) is going to be a winner. Great management as well so I was buying with them and hoping, and frankly it didn't take long, but some summer days kinda sucked!
Everybody is smiling big today. if you doubt, just look at the recent volume. The move from $3 to $4 came after the video of one of the patients came out where he is now lifting weights -- in 90 days. Talking, eating, writing. This guy signed his trial consent form by holding the pen in his mouth and others moved the paper.
Today's move up and strong close was because of the data. More to come.
Tim
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM